^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    DecisionDx®-Melanoma

    Company:
    Castle Biosci
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    DecisionDx-Melanoma is a 31- gene expression profile (GEP) test was designed to identify the risk of recurrence or metastasis in Stage I, II and III melanoma based on the biologic profile of genes within their tumor tissue. It is is performed on formalin-fixed, paraffin embedded (FFPE) primary tumor tissue from either a biopsy or excision.
    Cancer:
    Cutaneous Melanoma
    Method:
    RT-PCR